Personas / Equipo Humano

Cristina Ruiz Herguido

Buscador de publicaciones

Publicaciones

  • Ball M, Benito-Fernández S, Caride JP, Ruiz-Herguido C, Camprubí-Camprubí M and Sanchez deToledo J.

    Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation after Prolonged Circulatory Arrest.

    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS . (195): .

    [doi:10.3791/65266]

  • Marruecos L, Bertran J, Guillén Y, González J, Batlle R, López-Arribillaga E, Garrido M, Ruiz-Herguido C, Lisiero D, González-Farré M, Arce-Gallego S, Iglesias M, Nebreda AR, Miyamoto S, Bigas A and Espinosa L.

    IkBa deficiency imposes a fetal phenotype to intestinal stem cells.

    EMBO REP . 21(6): . Nº de citas: 8

    [doi:10.15252/embr.201949708]

  • Sinha R, Porcheri C, d'Altri T, González J, Ruiz-Herguido C, Rabbitts T, Espinosa L and Bigas A.

    Development of embryonic and adult leukemia mouse models driven by MLL-ENL translocation.

    EXP HEMATOL . 85: 13-19. Nº de citas: 6

    [doi:10.1016/j.exphem.2020.04.008]

  • Porcheri C, Golan O, Calero-Nieto FJ, Thambyrajah R, Ruiz-Herguido C, Wang X, Catto F, Guillén Y, Sinha R, González J, Kinston SJ, Mariani SA, Maglitto A, Vink CS, Dzierzak E, Charbord P, Göttgens B, Espinosa L, Sprinzak D and Bigas A.

    Notch ligand Dll4 impairs cell recruitment to aortic clusters and limits blood stem cell generation.

    EMBO JOURNAL . 39(8): .

    [doi:10.15252/embj.2019104270]

  • García-Alegría E, Lafita-Navarro MC, Aguado R, García-Gutiérrez L, Sarnataro K, Ruiz-Herguido C, Martín F, Bigas A, Canelles M and León J.

    NUMB inactivation confers resistance to imatinib in chronic myeloid leukemia cells.

    CANCER LETTERS . 375(1): 92-99. Nº de citas: 4

    [doi:10.1016/j.canlet.2016.02.037]

  • Gama-Norton L, Ferrando E, Ruiz-Herguido C, Liu Z, Guiu J, Islam AB, Lee SU, Yan M, Guidos CJ, López-Bigas N, Maeda T, Espinosa L, Kopan R and Bigas A.

    Notch signal strength controls cell fate in the haemogenic endothelium.

    NATURE COMMUNICATIONS . 6: 8510-8510. Nº de citas: 111

    [doi:10.1038/ncomms9510]

  • Martin A, Salvador F, Moreno-Bueno G, Floristán A, Ruiz-Herguido C, Cuevas EP, Morales S, Santos V, Csiszar K, Dubus P, Haigh JJ, Bigas A, Portillo F and Cano A.

    Lysyl oxidase-like 2 represses Notch1 expression in the skin to promote squamous cell carcinoma progression.

    EMBO JOURNAL . 34(8): 1090-1109. Nº de citas: 67

    [doi:10.15252/embj.201489975]

  • Guiu J, Bergen DJ, De Pater E, Islam AB, Ayllón V, Gama-Norton L, Ruiz-Herguido C, González J, López-Bigas N, Menendez P, Dzierzak E, Espinosa L and Bigas A.

    Identification of Cdca7 as a novel Notch transcriptional target involved in hematopoietic stem cell emergence.

    JOURNAL OF EXPERIMENTAL MEDICINE . 211(12): 2411-2423. Nº de citas: 33

    [doi:10.1084/jem.20131857]

  • Alaña L, Sesé M, Cánovas V, Punyal Y, Fernández Y, Abasolo I, de Torres I, Ruiz-Herguido C, Espinosa L, Bigas A, Y Cajal SR, Fernández PL, Serras F, Corominas M, Thomson TM and Paciucci R.

    Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression.

    MOLECULAR CANCER . 13: 74-74. Nº de citas: 25

    [doi:10.1186/1476-4598-13-74]

  • Nimmo R, Ciau-Uitz A, Ruiz-Herguido C, Soneji S, Bigas A, Patient R and Enver T.

    MiR-142-3p controls the specification of definitive hemangioblasts during ontogeny.

    DEV CELL . 26(3): 237-249. Nº de citas: 59

    [doi:10.1016/j.devcel.2013.06.023]